News | News By Subject | News by Disease News By Date | Search News

 News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
3 Biotechs With the Biggest and Most Promising Pipelines     2/20/2017
After Merck & Co. (MRK) & Eli Lilly (LLY) Alzheimer’s Failures, A Look at 7 Companies Still on the Hunt     2/20/2017
Another Drug Bites the Dust: Merck & Co. (MRK) Stops Late-Stage Alzheimer’s Study     2/16/2017
ArmaGen CEO: Phase II Data Shows Cognitive Improvement in Juvenile Hurler Syndrome Patients     2/16/2017
New FDA Report Cites 22 Drugs That Passed Phase II But Crashed and Burned in Phase III     2/8/2017
GlaxoSmithKline (GSK)'s Incoming CEO Preps for Deals, R&D Decisions on New Drugs     2/7/2017
These 5 Biotechs Are Battling Over the $10 Billion Hemophilia Market     2/6/2017
3rd Stemline (STML) Patient Died in Clinical Trial One Day Before $45 Million Public Offering     2/3/2017
Why This Big Biotech Could be Biogen (BIIB)'s Downfall     2/3/2017
Pfizer (PFE) Quietly Kills 3 Pipeline Programs     2/2/2017
6 Biopharma Companies Face Catalysts in February     1/31/2017
JPM17: Why the Key to Gene Therapy Could be in an Old Bay Area Warehouse     1/16/2017
JPM17: How Celgene (CELG) Wowed Yet Again     1/11/2017
Finding a Complementary Secondary Endpoint in Lupus Clinical Trials     1/10/2017
4 Fatal Deaths in Seattle Genetics (SGEN)' Early-Stage Trials of AML Drug     12/30/2016

Featured Stories
Could Marijuana Be the Next Miracle Drug For Treating Cancer?     2/20/2017
Allergan (AGN) R&D Chief Reveals 6 Drugs That Could be Potential Blockbusters     2/14/2017
5 Daring Biopharmas Mixing Drugs With Marijuana     2/6/2017
Scientists Highlight the Hopes and Fears of Cellectis (ALCLS)' CAR-T     1/26/2017
Novartis AG (NVS) Shows Off 13 Potential Blockbusters in Pipeline     1/25/2017
3 Drugs Heading To The FDA Soon     12/12/2016
10 Drugs That Could be Johnson & Johnson (JNJ)'s New Blockbusters     11/2/2016
A Look at BioMarin (BMRN)'s Potential Blockbuster and the Science Behind It All     10/21/2016
4 Small Biotechs That Could Give Gilead (GILD), Merck & Co. (MRK) Pfizer (PFE) Some Competition With NASH     10/7/2016
Why SCYNEXIS, Inc. (SCYX) Is Making A Run     10/7/2016
Despite Trial Deaths, Juno (JUNO) Could Still Be the CAR-T Leader     9/13/2016
In Juno (JUNO) Patient Deaths, Echoes Seen Of Earlier Failed Company Dendreon (DNDN)     7/11/2016
ASCO2016: What's Next For Cancer-Killing T-Cells After Strong ASCO Showings     6/8/2016
Down's Syndrome 'Can Be Treated With Green Tea,' Centre for Genomic Regulation Study     6/7/2016
Pharma's Big New Cancer Drug May Be An Old Red Dye     2/26/2016
Kalytera Therapeutics Announces Encouraging Results Of A Phase IIa Clinical Study For The Treatment Of Acute Graft Versus Host Disease     2/22/2017
ProMetic Life Sci (PFSCF.PK)'s PBI-4050 Continues To Demonstrate Early Evidence Of Efficacy Following Completion Of Idiopathic Pulmonary Fibrosis Phase II Clinical Trial     2/22/2017
Minoryx Therapeutics Receives Orphan Drug Designation From The US FDA For Its Lead Candidate MIN-102     2/22/2017
Soligenix (SNGX) Receives European Patent For Formulation Of Synthetic Hypericin To Treat Psoriasis     2/22/2017
SoCal's Cidara (CDTX) Stock Sinks as Lead Antifungal Med Flunks Trial     2/21/2017
OncoGenex (OGXI) Announces Phase II Apatorsen Data For Two Clinical Trials Presented At The OncoGenex (OGXI) 2017 Genitourinary Cancers Symposium     2/21/2017
Apitope Announces Positive ATX-MS-1467 Phase IIa Data In Relapsing Multiple Sclerosis     2/21/2017
Apitope Announces Positive ATX-MS-1467 Phase IIa Data In Relapsing Multiple Sclerosis     2/21/2017
OncoGenex (OGXI) Release: Data Support Continued Exploration Of Hsp27 Inhibition In Bladder And Prostate Cancers     2/21/2017
Lysogene Receives Orphan Drug Designation From EMA For LYS-GM101 For Treatment Of GM1 Gangliosidosis     2/21/2017
Cell Medica: Lead Cancer Immunotherapy Candidate Receives FDA Fast Track Designation     2/21/2017
Touchstone Innovations Plc Portfolio Company Cell Medica Granted FDA Fast Track Designation For Lead Oncology Product     2/21/2017
Immuron Completes Phase II NASH Clinical Trial Recruitment     2/21/2017
Xencor Release: Igg4-Related Disease Biomarker Development Update Presented From An Ongoing, Open-Label, Phase II Study Of Xmab5871 In Igg4-RD At The 3rd International Symposium On Igg4-Related Diseases & Fibrosis     2/20/2017
Phase II Study Supports Potential For Genentech (RHHBY)’s Tecentriq (Atezolizumab) Plus Avastin (Bevacizumab) For People With Locally Advanced Or Metastatic Renal Cell Carcinoma     2/20/2017

More News
No News Posted on that date

Career Tips
5 Best U.S. Regions for Life Science Jobs     2/21/2017
Here Are 5 Tricky Job Interview Questions You Might Get at Genentech (RHHBY), Regeneron (REGN), and Stratos     2/20/2017
How to Write the Best Cover Letter for a Research Scientist Job     2/16/2017
Real Life Employees Talk About Working At Allergan (AGN), Seattle Genetics (SGEN) And Shire (SHPG)     2/16/2017
How New Scientists Can Navigate The Tricky Waters Of A Life Science Career     2/16/2017
Biotech CEO To Job Seekers: How To Switch Out Before Burning Out On The Job     2/16/2017
Tired Of The U.S.? 6 Tips To Landing A Life Science Job Overseas     2/16/2017
Must-Read Tips For Getting Hired When You Don't Qualify For That Life Science Job     2/16/2017
Attention Bay Area: Chan-Zuckerberg's BIOHUB is Hiring Lots of Scientists     2/8/2017
Warning: Here's The Heartbreaking Truth About Postdoc Job Salaries in Life Sciences     2/8/2017
Explosion of Big Data Jobs: These Biotechs Are Hiring Huge Numbers of Data Scientists     2/3/2017
10 Unmistakable Signs It's Time To Kiss Your Biotech Employer Goodbye     2/1/2017
Don't Waste Your Time: Use These Strategies to Land That Life Science Job     2/1/2017
Lab Work Not for You: 10 Reasons Life Sci Grads Should Consider Recruiting     2/1/2017
Validation Engineer: How To Get This In-Demand Biotech Job     2/1/2017

Other News Sources
//-->